| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 01/10/2006 | CA2223918C Pyrrole derivatives and medicinal composition |
| 01/05/2006 | WO2006002284A1 Ubiquitin ligase inhibitors |
| 01/05/2006 | WO2006001894A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/05/2006 | WO2006000555A2 Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 01/05/2006 | WO2004091504A3 Substituted quinobenzoxazine analogs |
| 01/05/2006 | WO2004080976A8 Phthalazinone derivatives |
| 01/05/2006 | US20060004084 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 01/05/2006 | US20060004079 For therapy of cancer and the treatment of bacterial infections |
| 01/05/2006 | US20060004054 Administering 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline before or at the time angioplasty, coronary by-pass grafting or stent implantation |
| 01/05/2006 | US20060004037 Novel tricyclic compounds and related methods of treatment |
| 01/05/2006 | US20060004034 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene |
| 01/05/2006 | US20060004009 Ethylenediamine derivatives |
| 01/05/2006 | US20060004008 Topoisomerase inhibitors; useful as antibacterial, antifungal agents; cancer; structure is based on substituted benzo(i)phenanthridine ring where the ring carbon atoms at position 5 and 11 are optionally replaced by nitrogen |
| 01/05/2006 | US20060003997 Substituted benzo[e] [1,4] oxazino [3,2-g] isoindole compounds |
| 01/05/2006 | US20060003063 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 01/05/2006 | CA2571012A1 Tricyclic compounds and their use as mglur1 antagonists |
| 01/05/2006 | CA2570673A1 Compounds and methods for treating dyslipidemia |
| 01/05/2006 | CA2568752A1 Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 01/05/2006 | CA2567977A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/04/2006 | EP1610759A2 Substituted quinobenzoxazine analogs |
| 01/04/2006 | EP1546391A4 Energy transfer dyes, terminators and use thereof |
| 01/04/2006 | EP1546125A4 Fluorescent labeling reagents with multiple donors and acceptors |
| 01/04/2006 | EP1395585B1 Antibacterial agents |
| 01/04/2006 | EP1383741A4 Process for the preparation of benazepril |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1147088B1 6-arylphenanthridines with pde-iv inhibiting activity |
| 01/04/2006 | EP0820286B1 Tetrandrine for the treatment for ocular inflammation |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/03/2006 | US6982333 Intermediates in the synthesis of camptothecin and related compounds and synthesis thereof |
| 01/03/2006 | US6982276 Polymorphs of an epothilone analog |
| 12/29/2005 | WO2005123743A1 Extraction of alkaloids from opium |
| 12/29/2005 | WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/29/2005 | WO2005123087A2 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| 12/29/2005 | WO2005099687A3 Analogs of salinosporamide a |
| 12/29/2005 | WO2005062882A3 Rifamycin analogs and uses thereof |
| 12/29/2005 | WO2005046608B1 Novel compound, corresponding compositions, preparation and/or treatment methods |
| 12/29/2005 | US20050288364 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 12/29/2005 | US20050288352 Lactam fermentation products, e.g., pyrrolooxetanediones or pyrrolothietanediones especially containing a cyclohexane or cyclohexane ring, used as antimicrobial, anticancer or antiinflammatory agents; treating drug resistant cancer |
| 12/29/2005 | US20050288321 Alzheimer's disease ; 3-(2,3-dihydro-5,6-difluorobenzofur-7-yl)-4-[1-(piperidin-4-yl)-1H-indol-3-yl]pyrrole-2,5-dione; stimulating bone deposition |
| 12/29/2005 | US20050288319 e.g. 5-{3-[4-(4-Chloro-phenyl)-4-hydroxy-3,3-dimethyl-piperidin-1-yl]-propylidene}-1-oxy-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cycloheptene-7-carboxylic acid; chemokine receptor antagonist; antiinflammatory, antidiabetic agent; antiallergen; arteriosclerosis, asthma, arthritis |
| 12/29/2005 | US20050288317 Amido compounds and their use as pharmaceuticals |
| 12/29/2005 | US20050288316 Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists |
| 12/29/2005 | US20050288312 Bicyclic pyridine and pyrimidine p38 kinase inhibitors |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288213 Combination therapy for the treatment of obesity |
| 12/29/2005 | CA2569758A1 Extraction of alkaloids from opium |
| 12/29/2005 | CA2568379A1 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| 12/28/2005 | EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/28/2005 | EP1608660A1 Process for preparing topotecan from 10-hydroxy-4-(s) camptothecin |
| 12/28/2005 | EP1608659A1 Benzofuro-1,4-diazepin-2-one derivatives |
| 12/28/2005 | EP1608658A1 Condensed bicycl [3.1.0] hex-4-en derivatives useful as anti bacterial agents |
| 12/28/2005 | EP1608631A2 Bi-cyclic pyrimidine inhibitors of tgf beta |
| 12/28/2005 | EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 12/28/2005 | EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 12/28/2005 | EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 12/28/2005 | EP1140930B1 DIBENZO a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF |
| 12/27/2005 | US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology |
| 12/27/2005 | US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 12/22/2005 | WO2005121327A2 Biosynthetic gene cluster for the production of a complex polyketide |
| 12/22/2005 | WO2005121149A1 Furanopyrimidine compounds effective as potassium channel inhibitors |
| 12/22/2005 | WO2005121148A2 Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams |
| 12/22/2005 | WO2005121138A2 Heterotricyclic compounds for use as hcv inhibitors |
| 12/22/2005 | WO2005121094A1 Piperazine and piperidine derivatives as anti-hiv-agents |
| 12/22/2005 | WO2005113558A3 Simple stereocontrolled synthesis of salinosporamide a |
| 12/22/2005 | WO2005099702A3 R(-)-11-hydroxyaporphine derivatives and uses thereof |
| 12/22/2005 | WO2005062985A8 Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications |
| 12/22/2005 | WO2005058231A3 Rifamycin analogs and uses thereof |
| 12/22/2005 | US20050283006 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
| 12/22/2005 | US20050282863 Novel-N substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators |
| 12/22/2005 | US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 12/22/2005 | US20050282850 Tetrazolo[1,5-a]thieno[2,3-e]pyridine-4-carboxylic acid |
| 12/22/2005 | US20050282848 Synthesis and use of tetracyclic benzamide derivatives; antidiabetic agents; coupling isochromene anhydride with cyanobenzene compound and performing ring substitution reactions |
| 12/22/2005 | US20050282844 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 12/22/2005 | US20050282829 Furanopyrimidine compounds as potassium ion channel inhibitors |
| 12/22/2005 | US20050282826 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of beta-secretase |
| 12/22/2005 | US20050282818 Ubiquitin ligase inhibitors |
| 12/22/2005 | US20050282813 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile |
| 12/22/2005 | CA2568304A1 Furanopyrimidine compounds effective as potassium channel inhibitors |
| 12/22/2005 | CA2567043A1 Biosynthetic gene cluster for the production of a complex polyketide |
| 12/21/2005 | EP1606291A2 Efficient synthesis of pyropheophorbide a and its dervatives |
| 12/21/2005 | EP1606283A2 P38 inhibitors and methods of use thereof |
| 12/21/2005 | EP1606274A1 Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles |
| 12/21/2005 | EP1606268A1 Heterocyclic kinase inhibitors |
| 12/21/2005 | EP1606259A1 Process for the oxidation of secondary amines into the corresponding nitroxides |
| 12/21/2005 | EP1606254A1 2,4,6-phenyl substituted cyclic ketoenols |
| 12/21/2005 | EP1605938A2 Antibacterial agents |
| 12/21/2005 | EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function |
| 12/21/2005 | EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 12/21/2005 | EP1261625B1 Memno peptides, a process for their preparation and their use |
| 12/21/2005 | EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation |
| 12/21/2005 | EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 12/21/2005 | EP1090007B1 Cinoxacin lanthanide chelates and their use as biomolecular probes |
| 12/21/2005 | CN1711265A Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents |
| 12/21/2005 | CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity |
| 12/21/2005 | CN1232508C Cyclization process step in making of quinolones and phenodiazine |
| 12/20/2005 | US6977268 Diacid isoindoleine amide derivative |
| 12/20/2005 | US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
| 12/20/2005 | CA2338206C High affinity ligands for nociceptin receptor orl-1 |
| 12/20/2005 | CA2174127C Phenylsulfonyl ureas, processes for their preparation, and their use as herbicides and plant growth regulators |